Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
1.98
-0.02 (-1.00%)
At close: May 14, 2025, 3:59 PM
2.00
1.27%
After-hours: May 14, 2025, 04:00 PM EDT
-1.00% (1D)
| Bid | 1.95 |
| Market Cap | 273.11M |
| Revenue (ttm) | 3.69M |
| Net Income (ttm) | -47.76M |
| EPS (ttm) | -0.4 |
| PE Ratio (ttm) | -4.94 |
| Forward PE | -4.26 |
| Analyst | Buy |
| Ask | 2 |
| Volume | 1,128,757 |
| Avg. Volume (20D) | 1,498,505 |
| Open | 2.00 |
| Previous Close | 2.00 |
| Day's Range | 1.95 - 2.01 |
| 52-Week Range | 0.77 - 4.08 |
| Beta | 1.19 |
About CMPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+17.89%
Compass Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+6.51%
Compass Therapeutics shares are trading higher after Guggenhiem initiated coverage on the stock with a Buy rating and announced a price target of $12.
